FIELD: medicine.
SUBSTANCE: for tissue ischemia correction, in the reduced blood circulation environment an isolated pedicle skin flap is simulated in a laboratory animal. On the first, third and fifth experimental days, recombinant erythropoietin 50 IU/kg is injected subcutaneously.
EFFECT: method provides correction of the survival rate values of ischemic tissue of an isolated skin flap with a greater area of healthy tissue in 1,5 times in comparison with control animals, including due to the effective doses developed for such experiment and regiment of the drug.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH RESVERATROL | 2012 |
|
RU2511061C1 |
METHOD FOR INCREASING SKIN GRAFT SURVIVAL IN REDUCED CIRCULATION ENVIRONMENT WITH USE OF DIHYDROQUERCETIN | 2014 |
|
RU2547786C1 |
METHOD FOR IMPROVING SURVIVAL RATE OF ISCHEMIC TISSUES (ISOLATED SKIN PEDICLE FLAP) IN REDUCED BLOOD CIRCULATION | 2010 |
|
RU2429547C1 |
METHOD FOR PHARMACOLOGICAL STIMULATION OF PEDICLE SKIN FLAP SURVIVAL WITH NICORANDYL | 2012 |
|
RU2507598C1 |
METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH SILDENAFIL | 2012 |
|
RU2498414C1 |
METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH MINOXIDIL | 2012 |
|
RU2497201C1 |
METHOD FOR PREVENTION OF ISCHEMIA OF RETINA WITH ERYTHROPOETIN EXPERIMENTALLY | 2013 |
|
RU2539629C1 |
METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH L-NORVALINE | 2012 |
|
RU2513619C1 |
METHOD FOR INCREASING SURVIVAL RATE OF ISOLATED SKIN PEDICLE FLAP IN ANIMALS HAVING REDUCED ANTIOXIDATION BACKGROUND | 2002 |
|
RU2283116C2 |
METHOD FOR RECOMBINANT ERYTHROPOIETIN CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITROGEN OXIDE DEFICIENCY | 2009 |
|
RU2409873C1 |
Authors
Dates
2011-12-27—Published
2010-05-27—Filed